ArticleNature2020
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- NK cell immunotherapy after analytic treatment interruption is associated with HIV viral control.Molecular therapy. Advances · 2026Article
- Commentary on LRAs targeting NF-κB with epigenetic and mutational impacts on HIV latency.iMetaOmics · 2024Article
- Review
- CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.The Journal of clinical investigation · 2021Article
Corrections and comments
- Erratum for
Authors and funding
28 authors.
Julia Bergild McBrienEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Maud MavignerDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Lavinia FranchittiEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
S Abigail SmithEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Erick WhiteEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Gregory K TharpEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Hasse WalumEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Kathleen Busman-SahayVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Christian R Aguilera-SandovalInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
William O ThayerInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Rae Ann SpagnuoloInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Martina KovarovaInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Angela WahlInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Barbara CervasiEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
David M MargolisInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thomas H VanderfordEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Diane G CarnathanEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Mirko PaiardiniEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Jeffrey D LifsonAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
John H LeeNantKwest, Culver City, CA, USA.
Jeffrey T SafritNantKwest, Culver City, CA, USA.
Steven E BosingerEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Jacob D EstesVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Cynthia A DerdeynEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
J Victor GarciaInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Deanna A KulpaEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Ann ChahroudiDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Guido SilvestriEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. gsilves@emory.edu.
Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MCollaboratory of AIDS Researchers for Eradication (CARE)UM1AI126619 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2016 to 2020
$23.2MAntiviral role of CD8+ T cells in ART-treated SIV-infected macaquesR01AI125064 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2016 to 2025
$8.7MMechanisms of SIV suppression by CD8+ lymphocytesR01AI090797 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2010 to 2013
$3.2MNIAID NIH HHS R01 AI090797NIAID NIH HHS UM1 AI126619NIH HHS P51 OD011132
Abstract
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
PMID
32015546What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.